new post
StocksRunner logo
mail
search
 
menu
 
Arvinas
$13.36
-0.22%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

ARVN Stock Analysis & IQ Rating | Arvinas

 
 

ARVN

 

Arvinas

$13.36

 
-$0.03 | -0.22%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$18.93
 
 
MKT CAP
$839.81M
 
52W Low
$5.9
 
 
VOL
$726.10K
 
P/E Ratio
N/A
 
 
AVG VOL
$814.71K
 
RSI
57.47
 
 
TREND
Uptrend
 
 
 

ARVN Stock IQ

 
lock  Login to see Arvinas (ARVN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

ARVN Target Price

 
 
 

Strengths

 
 

ARVN Rewards

 Upgraded on attractively valued

 
 

ARVN Price Performance

 
 

$13.39   (-0.22%)

$12.79   (+4.46%)

$9.75   (+37.03%)

$8.7   (+53.56%)

 
 
1year
6month
3month
1month

ARVN Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

ARVN Earnings Sentiment Below analyst estimate
ARVN Earnings Sentiment Reported a strong earnings
ARVN Earnings Sentiment Eps growth

Rating

×

Rating

ARVN Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

Activity

×

Activity

Future

×

Future

ARVN Analysts Opinion

ARVN Analysts opinion is negative and it remained unchanged from the past 3 months

ARVN Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

44%
Consensus Rating
100%
Buy
Opinion
NA
Trend
Score
NA
Potential
Score
ARVN Street Sentiment

ARVN Street Sentiment is unimpressive and have negative views on the near-term outlook

ARVN Risk Level

ARVN has Low risk level

ARVN Risk Level
Low
LOW
HIGH

ARVN Performance Sentiment

Sentiments overview associated with events and the stock performance

44%
Positive
4 out of 9
events present
56%
Negative
5 out of 9
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$11.44
Resistance Price
$13.65
Current Price Range
$13.36
$11.44
$13.65
Show methods +
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
100%
Consensus Rating
STRONG BUY
4
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm

Jan 07, 2026

 

Upgrade

 

Buy

 

Citigroup

 

Nov 11, 2025

 

Reiterate

 

Overweight

 

Stephens

 

Nov 07, 2025

 

Reiterate

 

Overweight

 

Barclays

 

Oct 30, 2025

 

Reiterate

 

Buy

 

BTIG

 
 
 
Runners Also Watch
Close Price
Change
 

PFE

Pfizer

26.58

-2.49%

 
 
 
ARVN Latest Analysis +
 
 
FAQ About ARVN Stock Insights
 

What is ARVN current stock price?

What are ARVN stock strengths?

What is ARVN Risk Level?

What is ARVN market cap and volume?

What is ARVN current Stock IQ?

Should I buy ARVN stock right now?

Is ARVN a Strong Buy right now?

What does a 'Strong Buy' rating mean for ARVN?

What does a 'Strong Sell' rating mean for ARVN?

What factors influence ARVN's Stock IQ?

 
 
StocksRunner

Explore our ARVN Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored ARVN Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our ARVN Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

ARVN

 

Arvinas

 
Set Alerts
 
 

Current Price

 

$13.36

 
-$0.03 | -0.22%
 
 
52W High
$18.93
 
 
MKT CAP
$839.81M
 
52W Low
$5.9
 
 
VOL
$726.10K
 
P/E Ratio
N/A
 
 
AVG VOL
$814.71K
 
RSI
57.47
 
 
TREND
Uptrend
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 

Runners Also Watch

 
 
 
Symbol
Close
Change
 

PFE

Pfizer

26.58

-2.49%

 
 
 
 
 
user
 
 
 
 

ARVN Price Performance

 
 

$13.39   (-0.22%)

$12.79   (+4.46%)

$9.75   (+37.03%)

$8.7   (+53.56%)

 
 
1year
6month
3month
1month
 

ARVN Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

ARVN Earnings Sentiment Below analyst estimate
ARVN Earnings Sentiment Reported a strong earnings
ARVN Earnings Sentiment Eps growth

Rating

×

Rating

ARVN Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

Activity

×

Activity

Future

×

Future

ARVN Analysts Opinion

ARVN Analysts opinion is negative and it remained unchanged from the past 3 months

ARVN Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

44%
Consensus Rating
100%
Buy
Opinion
NA
Trend
Score
NA
Potential
Score
ARVN Street Sentiment

ARVN Street Sentiment is unimpressive and have negative views on the near-term outlook

ARVN Risk Level

ARVN has Low risk level

ARVN Risk Level
Low
LOW
HIGH
ARVN Performance Sentiment
Sentiments overview associated with events and the stock performance.
44%
Positive
4 out of 9
events present
56%
Negative
5 out of 9
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$11.44
Resistance Price
$13.65
Current Price Range
$13.36
$11.44
$13.65
Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%
Consensus Rating
STRONG BUY
4
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm
Jan 07, 2026
Upgrade
Buy
Citigroup
Nov 11, 2025
Reiterate
Overweight
Stephens
Nov 07, 2025
Reiterate
Overweight
Barclays
Oct 30, 2025
Reiterate
Buy
BTIG
 
 
 
 

ARVN Stock IQ

 
 
 
lock  Login to unlock Arvinas (ARVN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

ARVN Rewards

 Upgraded on attractively valued

 
 
 

ARVN Latest Analysis

 
 
 

Arvinas Inc. (ARVN) Makes Significant Progress on Oncology and Neurology Trials. Arvinas Inc. (NASDAQ:ARVN) is one of the best cancer stocks to invest in now. On February 24 Arvinas Inc. (NASDAQ:ARVN) delivered solid fourth-quarter and full-year results that affirmed progress across pipeline development. During the year the company submitted its first new drug application setting the stage for potential FDA approval of a PROTAC degrader. The [….]

 

Mon Mar 2, 2026

$13.39 | +0.90%
 
Activity
Earnings

Arvinas Inc. (NASDAQ:ARVN) Q4 2025 Earnings Call Transcript. Arvinas Inc. (NASDAQ:ARVN) Q4 2025 Earnings Call Transcript February 24 2026 Arvinas Inc. misses on earnings expectations. Reported EPS is $-1.1 EPS expectations were $-0.55. Operator: Hello and welcome to the Arvinas fourth quarter 2025 earnings call. All lines have been placed on mute to prevent any background noise. After the speakers’. remarks there will [….]

 

Wed Feb 25, 2026

$13.30 | +7.48%
 
Earnings

Arvinas GAAP EPS of -$1.10 misses by $0.62 revenue of $9.5M misses by $27.76M.

 

Tue Feb 24, 2026

$12.37 | +0.57%
 
Earnings

Arvinass Earnings Outlook. ) is set to give its latest quarterly earnings report on Tuesday 2026-02-24. Here'.s what investors need to know before the announcement.Analysts estimate that Arvinas will report an The announcement from Arvinas is eagerly anticipated with investors seeking news of surpassing estimates and favorable guidance for the next quarter.It'.s worth noting for new investors that guidance can be a key determinant of stock price movements.The company'.s EPS beat by $

 

Mon Feb 23, 2026

$12.30 | +2.59%
 
Earnings

Arvinas (ARVN) chief medical officer Berkowitz sells $67594 in stock.

 

Wed Feb 18, 2026

$11.82 | +3.32%
 
Activity

Arvinas CSO Cacace sells $54598 in shares.

 

Wed Feb 18, 2026

$11.82 | +3.32%
 
Activity

Arvinas appoints new president and CEO. leadership transition announced.

 

Thu Feb 12, 2026

$11.84 | -9.59%
 
Activity
 
 
 
 
 
StocksRunner

Discover ARVN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of ARVN. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our ARVN Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ARVN Stock trends

ARVN Stock performance

ARVN Stock analysis

ARVN investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

ARVN Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post